Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma
- 期刊名称Clinical Ophthalmology
- 作者Brouzas, D.
- 电子ISSN1177-5483
- 文件大小592.50KB
- 发表时间2009-11
- DOI10.2147/opth.s7698
Pseudobulbar affect: prevalence and managementSimmons, Zachary; Ahmed, Aiesha · Therapeutics and Clinical Risk Management · 2013
Pediatric psoriasis: an updateSilverberg, · Therapeutics and Clinical Risk Management · 2009
Xerostomia induced by radiotherapyAlimi, David · Therapeutics and Clinical Risk Management · 2015
Fatty liver in childrenRafeey, mandana; Mogaddasi, ; Hasani, ; Ghaffari, · Therapeutics and Clinical Risk Management · 2009
Bevacizumab for glioblastomaNarita, Yoshitaka · Therapeutics and Clinical Risk Management · 2015
Postoperative ileus: strategies for reductionSaclarides, Theodore · Therapeutics and Clinical Risk Management · 2008
Treating psoriasis with adalimumabGordon, Kenneth · Therapeutics and Clinical Risk Management · 2008
A review of nasal polyposisNewton, Jonathan · Therapeutics and Clinical Risk Management · 2008